These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33838306)

  • 1. Discovery of effective phosphodiesterase 2 inhibitors with antioxidant activities for the treatment of Alzheimer's disease.
    Jiang MY; Han C; Zhang C; Zhou Q; Zhang B; Le ML; Huang MX; Wu Y; Luo HB
    Bioorg Med Chem Lett; 2021 Jun; 41():128016. PubMed ID: 33838306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer's disease.
    Zhang C; Zhou Q; Wu XN; Huang YD; Zhou J; Lai Z; Wu Y; Luo HB
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):260-270. PubMed ID: 29271265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors.
    Morriello GJ; Dwyer MP; Chen Y; Ginetti AT; Xu S; Lu J; Abeywickrema P; Wang D; Crespo A; Cabalu TD; Wilson JE; Stachel SJ; Paone DV; Sinz C
    Bioorg Med Chem Lett; 2021 Jul; 44():128082. PubMed ID: 33991626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: Structure-based virtual screening, optimization and biological evaluation.
    Qiu X; Huang Y; Wu D; Mao F; Zhu J; Yan W; Luo HB; Li J
    Bioorg Med Chem; 2018 Jan; 26(1):119-133. PubMed ID: 29174506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.
    Zhou LY; Zhu Y; Jiang YR; Zhao XJ; Guo D
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4180-4184. PubMed ID: 28751142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Luo XT; Wang CM; Liu Y; Huang ZG
    Eur J Med Chem; 2015 Oct; 103():302-11. PubMed ID: 26363866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis of novel purin-6-one derivatives as phosphodiesterase 2 (PDE2) inhibitors: The neuroprotective and anxiolytic-like effects.
    Huang XF; Cao YJ; Zhen J; Zhang DW; Kong R; Jiang WT; Xu Y; Song GQ; Ke HM; Liu L
    Bioorg Med Chem Lett; 2019 Feb; 29(3):481-486. PubMed ID: 30554955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel Phosphodiesterase-2A Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay.
    Zhang C; Feng LJ; Huang Y; Wu D; Li Z; Zhou Q; Wu Y; Luo HB
    J Chem Inf Model; 2017 Feb; 57(2):355-364. PubMed ID: 28055196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
    Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
    ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a new series of [1,2,4]triazolo[4,3-a]quinoxalines as dual phosphodiesterase 2/phosphodiesterase 10 (PDE2/PDE10) inhibitors.
    Andrés JI; Buijnsters P; De Angelis M; Langlois X; Rombouts F; Trabanco AA; Vanhoof G
    Bioorg Med Chem Lett; 2013 Feb; 23(3):785-90. PubMed ID: 23260348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Evaluation of Dihydropyranopyrazole Derivatives as Novel PDE2 Inhibitors for the Treatment of Alzheimer's Disease.
    Zhou Y; Li J; Yuan H; Su R; Huang Y; Huang Y; Li Z; Wu Y; Luo H; Zhang C; Huang L
    Molecules; 2021 May; 26(10):. PubMed ID: 34069639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel multi target-directed ligands targeting 5-HT
    Lanthier C; Payan H; Liparulo I; Hatat B; Lecoutey C; Since M; Davis A; Bergamini C; Claeysen S; Dallemagne P; Bolognesi ML; Rochais C
    Eur J Med Chem; 2019 Nov; 182():111596. PubMed ID: 31419776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 2,5-dihydroxyterephthalamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Song Q; Li Y; Cao Z; Liu H; Tian C; Yang Z; Qiang X; Tan Z; Deng Y
    Bioorg Med Chem; 2018 Dec; 26(23-24):6115-6127. PubMed ID: 30470598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment.
    Jourdan JP; Since M; El Kihel L; Lecoutey C; Corvaisier S; Legay R; Sopkova-de Oliveira Santos J; Cresteil T; Malzert-Fréon A; Rochais C; Dallemagne P
    Eur J Med Chem; 2016 May; 114():365-79. PubMed ID: 27046230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer's disease.
    Eslami M; Nezafat N; Negahdaripour M; Ghasemi Y
    J Biomol Struct Dyn; 2019 Nov; 37(18):4825-4839. PubMed ID: 30689517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro evaluation of vanillin derivatives as multi-target therapeutics for the treatment of Alzheimer's disease.
    Blaikie L; Kay G; Kong Thoo Lin P
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127505. PubMed ID: 32822761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties.
    Xie SS; Lan JS; Wang XB; Jiang N; Dong G; Li ZR; Wang KD; Guo PP; Kong LY
    Eur J Med Chem; 2015 Mar; 93():42-50. PubMed ID: 25656088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.